减少唇腭裂患儿阿片类药物使用方案:多学科质量改进项目
该质量改进项目针对唇腭裂修复患儿,通过识别关键驱动因素并实施围手术期教育、术中疼痛控制标准化及术后优先非阿片类药物等干预,将术后阿片类药物用量从0.30 mg/kg吗啡当量降至0.14 mg/kg(p<0.001),且不增加住院时间或疼痛评分。
要点
- 多学科质量改进可显著降低唇腭裂患儿术后阿片用量。
- 干预后阿片用量从0.30降至0.14 mg/kg吗啡当量。
- 住院时间和疼痛评分无显著增加。
核心结论
- 通过识别关键驱动因素并针对围手术期教育、术中疼痛控制标准化及术后非阿片类药物优先,可在较短时间内减少唇腭裂修复术后阿片类药物使用。
研究设计与样本
- 质量改进项目,回顾性收集2015年1月1日至项目启动(2017年5月1日)数据,并追踪6个月研究期及后续14个月,最终样本624例患者。
主要发现
- 实施前(n=354)患儿术后平均接受0.30 mg/kg吗啡当量,实施后(n=270)平均接受0.14 mg/kg(p<0.001)。
- 住院时间实施前28.3小时 vs 实施后28.7小时(p=0.719),无显著增加。
- 术后<6小时疼痛评分1.78 vs 1.74(p=0.626),>6小时1.50 vs 1.49(p=0.924),均无显著差异。
临床怎么用
- 可借鉴该质量改进框架,通过围手术期教育、术中疼痛控制标准化及术后非阿片类药物优先策略减少阿片类药物使用。
局限性
- 证据等级为治疗性III级,为质量改进项目而非随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cleft repair requires multiple operations from infancy through adolescence, with repeated exposure to opioids and their associated risks. The authors implemented a quality improvement project to reduce perioperative opioid exposure in their cleft lip/palate population. METHODS: After identifying key drivers of perioperative opioid administration, quality improvement interventions were developed to address these key drivers and reduce postoperative opioid administration from 0.30 mg/kg of morphine equivalents to 0.20 mg/kg of morphine equivalents. Data were retrospectively collected from January 1, 2015, until initiation of the quality improvement project (May 1, 2017), tracked over the 6-month quality improvement study period, and the subsequent 14 months. Metrics included morphine equivalents of opioids received during admission, administration of intraoperative nerve blocks, adherence to revised electronic medical record order sets, length of stay, and pain scores. RESULTS: The final sample included 624 patients. Before implementation (n =354), children received an average of 0.30 mg/kg of morphine equivalents postoperatively. After implementation (n = 270), children received an average of 0.14 mg/kg of morphine equivalents postoperatively (p < 0.001) without increased length of stay (28.3 versus 28.7 hours; p = 0.719) or pain at less than 6 hours (1.78 versus 1.74; p = 0.626) or more than 6 hours postoperatively (1.50 versus 1.49; p = 0.924). CONCLUSIONS: Perioperative opioid administration after cleft repair can be reduced in a relatively short period by identifying key drivers and addressing perioperative education, standardization of intraoperative pain control, and postoperative prioritization of nonopioid medications and nonpharmacologic pain control. The authors' quality improvement framework has promise for adaptation in future efforts to reduce opioid use in other surgical patient populations. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Lee A, Chang BL, Yan C, et al. The Reducing Opioid Use in Children with Clefts Protocol: A Multidisciplinary Quality Improvement Effort to Reduce Perioperative Opioid Use in Patients Undergoing Cleft Surgery. Plast Reconstr Surg. 2020. PMID: 31985649. doi:10.1097/PRS.0000000000006471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。